Earnings Scheduled For November 30, 2021
Companies Reporting Before The Bell
• Hello Gr (NASDAQ:MOMO) is estimated to report quarterly earnings at $0.31 per share on revenue of $573.63 million.
Genetron Health Announced Release of Two Cancer Research Study Results at the Association for Molecular Pathology 2021 Annual Meeting
Genetron Holdings Limited (NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the release of two research results from its Seq-MRD® and FusionScan Plus product stu
Genetron Early Monday Reported Entered Strategic Partnership With NeoGenomics To Drive Global Oncology Drug Research, Development
Genetron Holdings Limited ((&ldquo, Genetron Health&rdquo, or the &ldquo, Company&rdquo, , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early
Genetron Health And Fosun Pharma Announce Exclusive Partnership To Commercialize Seq-MRD In China; Financial Details Not Disclosed
Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer
Genetron Health, IMPACT Therapeutics Join Forces For Synthetic Inhibitors For Cancer Applications
Genetron Holdings Limited (NASDAQ:GTH) has partnered with IMPACT Therapeutics to research and develop synthetic lethal inhibitors. The two parties will cooperate on…
Genetron Health And IMPACT Therapeutics Announce Partnership To Drive Development of Synthetic Lethal Product Pipeline
Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer
Genetron Added to FTSE Russell Global Equity Index Series
Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), today announced that Genetron will be added to the below FTSE Global Equity Index Series ("GEIS"), following
Genetron Holdings: Q2 Earnings Insights
Shares of Genetron Holdings (NASDAQ:GTH) remained unaffected after the company reported Q2 results.
Quarterly Results
Earnings per share were up 31.58% year over year to ($0.13), which beat the estimate of ($0.91).
Genetron Holdings Q2 EPS $(0.03) Up From $(0.19) YoY, Sales $21.80M Up From $14.40M YoY
Genetron Holdings (NASDAQ:GTH) reported quarterly losses of $(0.03) per share. This is a 84.21 percent increase over losses of $(0.19) per share from the same period last year. The company reported $21.80 million in
Earnings Scheduled For August 24, 2021
Companies Reporting Before The Bell
• 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter.